Related Experiment Video
Updated: Jul 19, 2026
04:33
CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
Published on: December 8, 2023
Rapid and simultaneous quantification of 4 urinary proteins by piezoelectric quartz crystal microbalance immunosensor
Yang Luo1, Ming Chen, Qianjun Wen
1Department of Laboratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, People's Republic of China.
Clinical Chemistry
|October 21, 2006
Summary
A new label-free piezoelectric quartz crystal microbalance (QCM) immunosensor array rapidly quantifies four urinary proteins, offering a sensitive and efficient alternative for diabetes nephropathy monitoring.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Clinical Diagnostics
Background:
- Urinary proteins are crucial biomarkers for diabetes nephropathy.
- Conventional protein quantification methods are slow and often use radioactive labels.
- A novel label-free immunosensor array was developed for simultaneous urinary protein analysis.
Purpose of the Study:
- To develop and validate a rapid, label-free piezoelectric quartz crystal microbalance (QCM) immunosensor array.
- To simultaneously quantify four key urinary proteins: microalbumin, alpha1-microglobulin, beta2-microglobulin, and IgG.
- To compare the performance of the QCM immunosensor array with established immunonephelometry methods.
Main Methods:
- Fabrication of a 2x5 piezoelectric immunosensor array using disposable quartz crystals.
- Immobilization of specific antibodies for target protein capture.
- Performance evaluation through calibration curves, precision, recovery, and specificity tests.
- Correlation analysis with immunonephelometry using 124 clinical urine samples.
Main Results:
- Simultaneous quantification of four urinary proteins achieved within 15 minutes.
- Analytical quantification range of 0.01-60 mg/L with high precision (CV <10%) and recovery (90.3%-109.1%).
- High sensitivity (>95.8%) and specificity (>76.3%) demonstrated, with minimal nonspecificity.
- Excellent agreement with immunonephelometry, as shown by Bland-Altman analysis.
Conclusions:
- The developed QCM immunosensor array is rapid, label-free, and highly sensitive.
- This system offers a valuable supplement to existing clinical chemistry assays.
- Potential for improved monitoring of diabetes nephropathy through efficient urinary protein analysis.
